The latest call
FetchingNuwellis, Inc. reported on 2026年11月12日. We are fetching the call transcript; its summary follows once the transcript is in.
Just reported
From Nuwellis, Inc.'s results release of 2026年11月12日. These are the company's first figures; its 10-Q or 10-K replaces them when filed.
Actual
US$2.2M
-0.2% y/y
+12% q/q
Guided
—
No guide given
Actual
-US$2.1M
Guided
—
No guide given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
| 指标 | 截至该日的 3 个月2026年9月30日 | 截至该日的 3 个月2025年9月30日 | 变动 |
|---|---|---|---|
| 营业收入合计 | US$2.2M | US$2.2M | -0.23% |
| 利润 | -US$2M | US$468K | -520.30% |
这些是单季度数字,不是滚动一年——本站其他地方的数字覆盖十二个月,会大得多。季节性业务在两者之间摆动很大:ServiceNow 在十二月季度赚 20 亿美元自由现金流,在六月季度只有 5 亿。
对比对象是去年同一季度,而不是分析师预测。要说“超预期”或“不及预期”需要一致预期数据,那是我们没有的授权数据——而搞错它比不提更糟。
Nuwellis, Inc. reported on 2026年11月12日. We are fetching the call transcript; its summary follows once the transcript is in.
“We have made meaningful progress in strengthening Nuwellis both commercially and financially. Year to date, console unit sales have nearly doubled, expanding our installed base and creating a larger opportunity to grow recurring circuit revenue. Although our third quarter faced a tough comparison against the prior-year period when we fulfilled a significant backorder, the underlying momentum in our business remains strong, as evidenced by the growth in our pediatric segment,”
逐字引自公告,且只在文件将其归于具名人士时才展示。
公告在开盘前或收盘后发布,因此区间从公告日前一个交易日的收盘价到公告日之后那个交易日的收盘价——无论哪种情况,反应都包含在内。
Aquadex SmartFlow System is indicated for the continuous ultrafiltration therapy for temporary (up to 8 hours) or extended (longer than 8 hours in patients who require hospitalization) use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. All treatments must be administered by a healthcare provider, within an outpatient or inpatient clinical setting, under physician prescription, both of whom having received training in extracorporeal therapies.
公司自己的描述,取自公告末尾。
The quote, the company description and the latest quarter come from Nuwellis’s earnings press release (an Item 2.02 8-K) filed 2026年11月12日. Earlier quarters come from its quarterly and annual reports, and the latest will be replaced once the official report is filed. 在 EDGAR 上阅读公告 股价已按拆股和分红复权。
US$4.94-1.6%11月13日 收盘
The latest quarter (ended 2026年9月30日) is from Nuwellis’s earnings press release of 2026年11月12日. It will be replaced by the official quarterly report (10-Q) once Nuwellis files it.